GlassScriptPhysician profile
Brett William Baker
NPI 1033524319
$5,639.35
in general payments reported to CMS, 2019-2025
11 companies · $1,332 in 2025
The $1,332 reported for 2025 was more than what 77% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $655 · 2024: $3,653 · 2025: $1,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,139 · Travel and Lodging: $1,500 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,139.35 |
| Travel and Lodging | $1,500.00 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $3,315.41 | 2024-2025 | |
| Abbvie INC. | $1,010.32 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Revolve |
| Davol INC. | $297.12 | 2024-2025 | Phasix Mesh |
| Mentor Worldwide LLC | $249.29 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Kerecis Limited | $183.67 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $158.93 | 2023 | Tenoglide |
| Abbott Laboratories | $135.02 | 2025 | Navitor |
| Dilon Technologies, INC. | $124.23 | 2023-2025 | Hemoblast Bellows |
| Piedmont Plus Innovation | $117.71 | 2023 | |
| Galderma Laboratories, L.P. | $24.17 | 2025 | Dysport |
| Vertex Pharmaceuticals Incorporated | $23.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.